Celularity Stock Analysis
| CELUW Stock | USD 0.05 0.00 0.000002% |
Celularity is overvalued with Real Value of 0.041 and Hype Value of 0.0617. The main objective of Celularity stock analysis is to determine its intrinsic value, which is an estimate of what Celularity is worth, separate from its market price. There are two main types of Celularity's stock analysis: fundamental analysis and technical analysis.
The Celularity stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Celularity is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Celularity Stock trading window is adjusted to America/New York timezone.
Celularity | Build AI portfolio with Celularity Stock |
Celularity Stock Analysis Notes
The company recorded a loss per share of 0.87. Celularity had not issued any dividends in recent years. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey. Celularity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people. For more info on Celularity please contact Robert MD at 908 768 2170 or go to https://www.celularity.com.Celularity Quarterly Total Revenue |
|
Celularity Investment Alerts
| Celularity is way too risky over 90 days horizon | |
| Celularity has some characteristics of a very speculative penny stock | |
| Celularity appears to be risky and price may revert if volatility continues | |
| Celularity has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 54.22 M. Net Loss for the year was (57.89 M) with profit before overhead, payroll, taxes, and interest of 39.23 M. | |
| Celularity has accumulated about 38 M in cash with (6.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Why Celularity Inc. Equity Warrant stock attracts strong analyst attention - Insider Strategy Insight - beatles.ru |
Celularity Profitablity
The company has Profit Margin (PM) of (1.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.52) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.52.Management Efficiency
The company has return on total asset (ROA) of (0.1742) % which means that it has lost $0.1742 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.3251) %, meaning that it generated substantial loss on money invested by shareholders. Celularity's management efficiency ratios could be used to measure how well Celularity manages its routine affairs as well as how well it operates its assets and liabilities.Celularity benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Technical Drivers
As of the 21st of July, Celularity shows the Mean Deviation of 14.85, downside deviation of 17.38, and Risk Adjusted Performance of 0.1132. Celularity technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Celularity downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Celularity is priced correctly, providing market reflects its regular price of 0.050000001 per share. As Celularity appears to be a penny stock we also recommend to validate its total risk alpha numbers.Celularity Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Celularity for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Celularity short-term fluctuations and highlight longer-term trends or cycles.
Celularity Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Celularity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Celularity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Celularity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Celularity Outstanding Bonds
Celularity issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Celularity uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Celularity bonds can be classified according to their maturity, which is the date when Celularity has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| CELARA 3875 02 NOV 27 Corp BondUS151191BB89 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| US15118JAA34 Corp BondUS15118JAA34 | View |
Celularity Predictive Daily Indicators
Celularity intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Celularity stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Celularity Forecast Models
Celularity's time-series forecasting models are one of many Celularity's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Celularity's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Celularity Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Celularity prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Celularity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Celularity. By using and applying Celularity Stock analysis, traders can create a robust methodology for identifying Celularity entry and exit points for their positions.
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey. Celularity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Celularity to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.